InsiderClue
Insiders · Profile

SCHAFFER DAVID

Director at 4D Molecular Therapeutics · Director at uniQure N.V. Filing since 29 Jan 2018. CIK 0001692929

FDMT 4D Molecular Therapeutics, Inc. Director · 7 trades QURE uniQure N.V. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
FDMT 4D Molecular Therapeutics, Inc.
22 Oct 2021
Director
Sold, plan not stated
1,900
$58.89K
0.2%
FDMT 4D Molecular Therapeutics, Inc.
21 Oct 2021
Director
Sold, plan not stated
22,820
$720.16K
2.5%
FDMT 4D Molecular Therapeutics, Inc.
20 Oct 2021
Director
Sold, plan not stated
11,565
$358.77K
1.2%
FDMT 4D Molecular Therapeutics, Inc.
30 Sep 2021
Director
Sold, plan not stated
12,385
$333.25K
1.3%
FDMT 4D Molecular Therapeutics, Inc.
29 Sep 2021
Director
Sold, plan not stated
16,871
$482.61K
1.7%
FDMT 4D Molecular Therapeutics, Inc.
28 Sep 2021
Director
Sold, plan not stated
13,912
$424.69K
1.4%
FDMT 4D Molecular Therapeutics, Inc.
27 Sep 2021
Director
Sold, plan not stated
19,332
$635.83K
1.9%
QURE uniQure N.V.
28 Jan 2020
Director
Sold, plan not stated
806
$50.19K
1.8%
QURE uniQure N.V.
28 Jan 2019
Director
Sold, plan not stated
1,210
$37.89K
2.6%
QURE uniQure N.V.
17 Jan 2019
Director
Sold, plan not stated
7,500
$230.33K
14.6%
QURE uniQure N.V.
29 Jan 2018
Director
Sold, plan not stated
2,878
$53.33K
15.8%
11 decisions on file.